”I am passionate about developing people and processes”
Restructuring in the Danish branch of the pharmaceutical company AstraZeneca has also led to managerial changes. The new Country Lead identifies patent expirations and increased pressure on prices as the greatest challenges.
Susanne Skovgaard Nickelsen has taken over as the new Country Lead in Denmark for AstraZeneca as of September 1. She takes over from Henrik Asmussen, who has been transferred to the company’s global offices in London.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
